NKT Role in the Regulation of the Inflammatory Bowel Disease
Launched by UNIVERSITY HOSPITAL, LILLE · Aug 30, 2016
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with PSC alone, IBD alone or PSC + IBD
- • Obtention of oral and written consent
- • Patients affiliated with the social security system
- Exclusion Criteria:
- • Minor patient
- • Suspicion of malignant lesion of the colon
- • Inability for information
- • person unable to consent, and not benefiting from a legal protection regimen
- • Person deprived of liberty
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Patients applied
Trial Officials
Pierre Desreumeaux, MD, PhD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials